Literature DB >> 28753078

Which is more effective for pain relief during fractionated carbon dioxide laser treatment: EMLA cream or forced cold air anesthesia?

Elif Sari1, Bulent Bakar2.   

Abstract

BACKGROUND AND AIM: The aim of this study was to compare the effectiveness of a eutectic mixture of local anesthetic (EMLA) cream and forced cold air anesthesia (FCAA) on pain control during ablative fractionated carbon dioxide (CO2) laser treatment.
METHODS: Fifteen volunteers participated in this prospective, controlled, split-face clinical study. EMLA cream was applied 60 minutes before the laser procedure on half of the face, and FCAA was performed on each subunit of the other half of the face. The laser procedure was performed on each half of the face. Patients rated their pain during the procedure using a pain scale scored from 0-10. Both doctor and nurse rated patient discomfort during the procedure using a scale scored from 0-10. The pain scores associated with both EMLA and FCAA sides of the face were compared statistically.
RESULTS: Patient pain scores and discomfort scores detected by doctor and nurse were not statistically different between EMLA and FCAA. There was no statistically significant difference between males and females.
CONCLUSION: Instead of using EMLA, FCAA-which can be applied in a shorter time-may be a cost-effective, simple, and safe local anesthesia method used in the ablative fractionated CO2 laser procedure.

Entities:  

Keywords:  EMLA; Fractionated carbon dioxide laser; Laser; forced cold air

Mesh:

Substances:

Year:  2017        PMID: 28753078     DOI: 10.1080/14764172.2017.1358458

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  1 in total

1.  Comparison of music and vapocoolant spray in reducing the pain of venous cannulation in children age 6-12: a randomized clinical trial.

Authors:  Masoomeh Ghasemi; Poria Hoseinialiabadi; Fatemeh Yazdanpanah; Maryam Askaryzadeh Mahani; Leila Malekyan; Kazem Najafi; Mohammadreza Arab; Mansour Arab; Hadi Ranjbar
Journal:  BMC Pediatr       Date:  2022-04-29       Impact factor: 2.567

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.